Compare Wockhardt with ALEMBIC - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs ALEMBIC - Comparison Results

WOCKHARDT     Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

ALEMBIC 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT ALEMBIC WOCKHARDT/
ALEMBIC
 
P/E (TTM) x -85.1 61.5 - View Chart
P/BV x 1.9 5.3 35.6% View Chart
Dividend Yield % 0.0 0.2 1.1%  

Financials

 WOCKHARDT   ALEMBIC
EQUITY SHARE DATA
    WOCKHARDT
Mar-18
ALEMBIC
Mar-18
WOCKHARDT/
ALEMBIC
5-Yr Chart
Click to enlarge
High Rs1,01272 1,405.6%   
Low Rs53234 1,567.8%   
Sales per share (Unadj.) Rs355.94.7 7,570.6%  
Earnings per share (Unadj.) Rs-60.36.1 -987.6%  
Cash flow per share (Unadj.) Rs-46.86.2 -748.8%  
Dividends per share (Unadj.) Rs0.010.20 5.0%  
Dividend yield (eoy) %00.4 0.3%  
Book value per share (Unadj.) Rs257.840.7 634.0%  
Shares outstanding (eoy) m110.63267.03 41.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.211.3 19.3%   
Avg P/E ratio x-12.88.7 -147.6%  
P/CF ratio (eoy) x-16.58.5 -194.7%  
Price / Book Value ratio x3.01.3 229.9%  
Dividend payout %03.3 -0.5%   
Avg Mkt Cap Rs m85,37914,139 603.8%   
No. of employees `0006.3NA-   
Total wages/salary Rs m9,371207 4,518.1%   
Avg. sales/employee Rs Th6,295.0NM-  
Avg. wages/employee Rs Th1,498.3NM-  
Avg. net profit/employee Rs Th-1,066.3NM-  
INCOME DATA
Net Sales Rs m39,3691,255 3,136.5%  
Other income Rs m1,202370 324.8%   
Total revenues Rs m40,5711,625 2,496.1%   
Gross profit Rs m18111 16.5%  
Depreciation Rs m1,49538 3,955.8%   
Interest Rs m2,5552 150,288.2%   
Profit before tax Rs m-2,830442 -640.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m01,212 0.0%   
Extraordinary Inc (Exp) Rs m-3,5820-   
Tax Rs m25724 1,073.1%   
Profit after tax Rs m-6,6691,630 -409.1%  
Gross profit margin %08.9 0.5%  
Effective tax rate %-9.15.4 -167.5%   
Net profit margin %-16.9129.8 -13.0%  
BALANCE SHEET DATA
Current assets Rs m33,7961,867 1,810.1%   
Current liabilities Rs m26,917591 4,553.0%   
Net working cap to sales %17.5101.6 17.2%  
Current ratio x1.33.2 39.8%  
Inventory Days Days7994 84.2%  
Debtors Days Days8974 121.3%  
Net fixed assets Rs m39,6641,791 2,214.8%   
Share capital Rs m553534 103.6%   
"Free" reserves Rs m27,96810,324 270.9%   
Net worth Rs m28,52210,858 262.7%   
Long term debt Rs m21,73141 52,745.4%   
Total assets Rs m81,62011,591 704.2%  
Interest coverage x-0.1260.9 -0.0%   
Debt to equity ratio x0.80 20,079.4%  
Sales to assets ratio x0.50.1 445.4%   
Return on assets %-5.014.1 -35.8%  
Return on equity %-23.415.0 -155.8%  
Return on capital %-7.715.2 -50.5%  
Exports to sales %01.5 0.0%   
Imports to sales %021.0 0.0%   
Exports (fob) Rs mNA19 0.0%   
Imports (cif) Rs mNA263 0.0%   
Fx inflow Rs m9,80719 50,552.1%   
Fx outflow Rs m1,789264 678.0%   
Net fx Rs m8,019-244 -3,280.6%   
CASH FLOW
From Operations Rs m684236 290.2%  
From Investments Rs m6,302-224 -2,813.6%  
From Financial Activity Rs m-7,695-27 28,927.4%  
Net Cashflow Rs m-664-15 4,486.5%  

Share Holding

Indian Promoters % 74.5 64.0 116.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.3 0.2 1,150.0%  
FIIs % 7.7 9.7 79.4%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 26.1 59.0%  
Shareholders   67,757 54,701 123.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT With:   PROCTER & GAMBLE HEALTH  CIPLA  TORRENT PHARMA  VENUS REMEDIES  WYETH  

Compare WOCKHARDT With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Zooms 1,030 Points, Nifty Tops 14,980-Mark; HDFC Bank Among Top Gainers(Closing)

Indian share markets witnessed huge buying interest during the extended closing hours today and ended their day on a strong note.

Related Views on News

ALEMBIC LTD Announces Quarterly Results (1QFY21); Net Profit Up 3.5% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, ALEMBIC LTD has posted a net profit of Rs 21 m (up 3.5% YoY). Sales on the other hand came in at Rs 131 m (down 49.7% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

WOCKHARDT Announces Quarterly Results (3QFY20); Net Profit Up 125.0% (Quarterly Result Update)

Jan 28, 2020 | Updated on Jan 28, 2020

For the quarter ended December 2019, WOCKHARDT has posted a net profit of Rs 192 m (up 125.0% YoY). Sales on the other hand came in at Rs 9 bn (down 16.9% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

WOCKHARDT Announces Quarterly Results (1QFY20); Net Profit Up 57.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, WOCKHARDT has posted a net profit of Rs 369 m (up 57.2% YoY). Sales on the other hand came in at Rs 9 bn (down 14.3% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

Intraday Trading for a Living(Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

Penny Stock Master Series: The Quest for 10X Profits in 10 Years(Profit Hunter)

Feb 12, 2021

This is first of the three part master series. In these editorials, I'll show you how to earn 10X returns from a penny stock portfolio over 10 years.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021(Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla(Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT SHARE PRICE


Feb 24, 2021 (Close)

TRACK WOCKHARDT

  • Track your investment in WOCKHARDT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WOCKHARDT - STERLING BIOTECH COMPARISON

COMPARE WOCKHARDT WITH

MARKET STATS